SEARCH

SEARCH BY CITATION

References

  • 1
    Melamud A, Palekar R, Singh A. Retinoblastoma. Am Fam Physician 2006; 73: 103944.
  • 2
    Corson TW, Gallie BL. One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma. Genes Chromosomes Cancer 2007; 46: 61734.
  • 3
    Francke U. Retinoblastoma and chromosome 13. Birth Defects Orig Artic Ser 1976; 12: 1314.
  • 4
    Fung Y-K, Murphree AL, T'Ang A, Qian J, Hinrichs SH, Benedict WF. Structural evidence for the authenticity of the human retinoblastoma gene. Science 1987; 236: 165761.
  • 5
    Knudson AGJr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971; 68: 8203.
  • 6
    Lee W-H, Bookstein R, Hong F, Young L-J, Shew J-Y, Lee EY-HP. Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 1987; 235: 13949.
  • 7
    Vogelstein B, Kinzler KW. The genetic basis of human cancer. New York, NY: McGraw-Hill Medical, 2002. 1744.
  • 8
    Draper GJ, Sanders BM, Brownbill PA, Hawkins MM. Patterns of risk of hereditary retinoblastoma and applications to genetic counselling. Br J Cancer 1992; 66: 21119.
  • 9
    Moolgavkar SH, Venzon DJ. Two-Event models for carcinogenesis: incidence curves for childhood and adult tumors. Math Biosci 1979; 47: 5577.
  • 10
    Fitzgerald PH, Stewart J, Suckling RD. Retinoblastoma mutation rate in New Zealand and support for the two-hit model. Hum Genet 1983; 64: 12830.
  • 11
    Shonkwiler R, Mistretta M, Varma V. A growth and division model for retinoblastoma. Math Biosci 2008; 211: 25564.
  • 12
    Bonaïti-Pellie C, Briard-Guillemot ML, Feingold J, Frezal J. Mutation theory of carcinogenesis in retinoblastoma. J Natl Cancer Inst 1976; 57: 26976.
  • 13
    Mastrangelo D, De Francesco S, Di Leonardo A, Lentini L, Hadjistilianou T. Does the evidence matter in medicine? The retinoblastoma paradigm. Int J Cancer 2007; 121: 25015.
  • 14
    Little MP. Are two mutations sufficient to cause cancer? Some generalizations of the two-mutation model of carcinogenesis of Moolgavkar, Venzon, and Knudson, and of the multistage model of Armitage and Doll. Biometrics 1995; 51: 127891.
  • 15
    Castéra L, Sabbagh A, Dehainault C, Michaux D, Mansuet-Lupo A, Patillon B, Lamar E, Aerts I, Lumbroso-Le Rouic L, Couturier J, Stoppa-Lyonnet D, Gauthier-Villars M, et al. MDM2 as a modifier gene in retinoblastoma. J Natl Cancer Inst 2010; 102: 18058.
  • 16
    Stiller C. Childhood cancer in Britain. Incidence, survival, mortality. Oxford: Oxford University Press, 2007. 1270.
  • 17
    Coles BLK, Angénieux B, Inoue T, Del Rio-Tsonis K, Spence JR, McInnes RR, Arsenijevic Y, van der Kooy D. Facile isolation and the characterization of human retinal stem cells. Proc Natl Acad Sci USA 2004; 101: 157727.
  • 18
    De Falco G, Giordano A. pRb2/p130: a new candidate for retinoblastoma tumor formation. Oncogene 2006; 25: 533340.
  • 19
    Knudson AG. Two genetic hits (more or less) to cancer. Nat Rev Cancer 2001; 1: 15762.
  • 20
    Vogel F. Genetics of retinoblastoma. Hum Genet 1979; 52: 154.
  • 21
    Houdayer C, Gauthier-Villars M, Laugé A, Pagès-Berhouet S, Dehainault C, Caux-Moncoutier V, Karczynski P, Tosi M, Doz F, Desjardins L, Couturier J, Stoppa-Lyonnet D. Comprehensive screening for constitutional RB1 mutations by DHPLC and QMPSF. Hum Mutat 2004; 23: 193202.
  • 22
    Czeizel A, Gárdonyi J. Retinoblastoma in Hungary, 1960–1968. Humangenetik 1974; 22: 1538.
  • 23
    McCullagh P, Nelder JA. Generalized linear models, 2nd edn. Monographs on statistics and applied probability 37. Boca Raton, FA: Chapman and Hall/CRC, 1989. 1526.
  • 24
    R Project. R version 2.11.1, 2010. Available at: http://www.r-project.org/. Accessed on 20 July 2010.
  • 25
    Numerical Algorithms Group. NAG FORTRAN Library Mark 22. Oxford: Numerical Algorithms Group, 2009.
  • 26
    Davison AC, Hinkley DV. Bootstrap methods and their application. Cambridge: Cambridge University Press, 1997. 1592.
  • 27
    Akaike H. Likelihood of a model and information criteria. J Econom 1981; 16: 314.
  • 28
    Akaike H. Information theory and an extension of the maximum likelihood principle. In: Petrov BN, Czáki F, eds. International symposium on information theory, 2nd edn. Budapest: Akademia Kiadó, 1973. 26781.
  • 29
    Barishak YR. Embryology of the eye and its adnexa. Basel: Karger, 2001. 1132.
  • 30
    Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986; 323: 6436.
  • 31
    Knudson AG, Jr, Hethcote HW, Brown BW. Mutation and childhood cancer: a probabilistic model for the incidence of retinoblastoma. Proc Natl Acad Sci USA 1975; 72: 511620.
  • 32
    Hethcote HW, Knudson AG, Jr. Model for the incidence of embryonal cancers: application to retinoblastoma. Proc Natl Acad Sci USA 1978; 75: 24537.
  • 33
    Dunn JM, Phillips RA, Becker AJ, Gallie BL. Identification of germline and somatic mutations affecting the retinoblastoma gene. Science 1988; 241: 1797800.
  • 34
    Hernando E, Nahlé Z, Juan G, Diaz-Rodriguez E, Alaminos M, Hemann M, Michel L, Mittal V, Gerald W, Benezra R, Lowe SW, Cordon-Cardo C. Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature 2004; 430: 797802.
  • 35
    Dimaras H, Khetan V, Halliday W, Orlic M, Prigoda NL, Piovesan B, Marrano P, Corson TW, Eagle RC, Jr, Squire JA, Gallie BL. Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma. Hum Mol Genet 2008; 17: 136372.
  • 36
    Marees T, Moll AC, Imhof SM, de Boer MR, Ringens PJ, van Leeuwen FE. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up. J Natl Cancer Inst 2008; 100: 17719.
  • 37
    Rushlow D, Piovesan B, Zhang K, Prigoda-Lee NL, Marchong MN, Clark RD, Gallie BL. Detection of mosaic RB1 mutations in families with retinoblastoma. Hum Mutat 2009; 30: 84251.
  • 38
    Lohmann DR, Brandt B, Höpping W, Passarge E, Horsthemke B. The spectrum of RB1 germ-line mutations in hereditary retinoblastoma. Am J Hum Genet 1996; 58: 9409.
  • 39
    Bamne MN, Ghule PN, Jose J, Banavali SD, Kurkure PA, Amare Kadam PS. Constitutional and somatic RB1 mutation spectrum in nonfamilial unilateral and bilateral retinoblastoma in India. Genet Test 2005; 9: 20011.
  • 40
    Zhu X, Dunn JM, Goddard AD, Squire JA, Becker A, Phillips RA, Gallie BL. Mechanisms of loss of heterozygosity in retinoblastoma. Cytogenet Cell Genet 1992; 59: 24852.
  • 41
    Hagstrom SA, Dryja TP. Mitotic recombination map of 13cen-13q14 derived from an investigation of loss of heterozygosity in retinoblastomas. Proc Natl Acad Sci USA 1999; 96: 29527.
  • 42
    de Andrade AFB, da Hora Barbosa R, Vargas FR, Ferman S, Eisenberg AL, Fernandes L, Bonvicino CR. A molecular study of first and second RB1 mutational hits in retinoblastoma patients. Cancer Genet Cytogenet 2006; 167: 436.
  • 43
    Weinberg RA. The biology of cancer. New York, NY: Garland Science, 2007. 1796.
  • 44
    Richter S, Vandezande K, Chen N, Zhang K, Sutherland J, Anderson J, Han L, Panton R, Branco P, Gallie B. Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma. Am J Hum Genet 2003; 72: 25369.
  • 45
    Tan WY, Singh KP. A mixed model of carcinogenesis with applications to retinoblastoma. Math Biosci 1990; 98: 21125.
  • 46
    Morris JA. Spontaneous mutation rate in retinoblastoma. J Clin Pathol 1990; 43: 4968.
  • 47
    Dyer MA, Bremner R. The search for the retinoblastoma cell of origin. Nat Rev Cancer 2005; 5: 91101.
  • 48
    Xu XL, Fang Y, Lee TC, Forrest D, Gregory-Evans C, Almeida D, Liu A, Jhanwar SC, Abramson DH, Cobrinik D. Retinoblastoma has properties of a cone precursor tumor and depends upon cone-specific MDM2 signaling. Cell 2009; 137: 101831.
  • 49
    Reulen RC, Zeegers MP, Wallace WHB, Frobisher C, Taylor AJ, Lancashire ER, Winter DL, Hawkins MM. Pregnancy outcomes among adult survivors of childhood cancer in the British Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev 2009; 18: 223947.